Search

everythinglearnresearchcommunity

for

Search:↓

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Standardized photography protocols help clinicians assess and monitor hair loss effectively.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Trichoscopy is a quick, cost-effective tool for diagnosing different hair loss conditions.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.